Which statement about troponin testing is true?

Which statement about troponin testing is true?

• A. cTnI is released by injured myocardial filaments
• B. Troponin elevations are reliably detected immediately after onset
• C. CK-MB is the preferred marker over troponin
• D. Troponin testing is not helpful in ACS

Answer: (A)

Cardiac troponin serves as a highly specific indicator of myocardial injury. The statement that cTnI is released by injured myocardial filaments is correct because troponin I is a component of the cardiac contractile apparatus and is released into the bloodstream when cardiomyocytes are damaged, making it a specific marker for myocardial injury. Troponin elevations do not appear immediately after symptom onset; they typically rise after about 3–4 hours, peak around 12–24 hours, and can remain elevated for days to over a week. That’s why relying on an immediate rise would be misleading. CK-MB used to be considered the preferred marker, but troponin is more sensitive and specific for myocardial injury, so CK-MB is not the preferred test over troponin. Troponin testing is helpful in evaluating suspected acute coronary syndrome; it aids diagnosis and risk stratification, not something that would be considered unhelpful.

Cardiac troponin serves as a highly specific indicator of myocardial injury. The statement that cTnI is released by injured myocardial filaments is correct because troponin I is a component of the cardiac contractile apparatus and is released into the bloodstream when cardiomyocytes are damaged, making it a specific marker for myocardial injury.

Troponin elevations do not appear immediately after symptom onset; they typically rise after about 3–4 hours, peak around 12–24 hours, and can remain elevated for days to over a week. That’s why relying on an immediate rise would be misleading.

CK-MB used to be considered the preferred marker, but troponin is more sensitive and specific for myocardial injury, so CK-MB is not the preferred test over troponin.

Troponin testing is helpful in evaluating suspected acute coronary syndrome; it aids diagnosis and risk stratification, not something that would be considered unhelpful.